Clinical Trials Browser

INDUSTRY × AZD5305 × Clear all

NCT05797168 2026-06-03

FONTANA

Phase 1/2 Recruiting

GynecologicThoracic

Adenocarcinoma of Lung, Ovarian Neoplasms, Endometrial Neoplasms

NCT05367440 2026-06-01

PETRANHA

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT06120491 2026-05-27

EvoPAR-PR01

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT06952803 2026-05-19

EvoPAR-PR02

Phase 3 Recruiting

Prostatic Neoplasms

NCT05123482 2026-05-18

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Phase 1/2 Recruiting

BreastGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06380751 2026-05-15

EvoPAR-BR01

Phase 3 Recruiting

Advanced Breast Cancer

NCT02264678 2026-05-12

Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

Phase 1 Active not recruiting

Ovarian Neoplasms

NCT07336446 2026-05-01

ANDROMEDA

Phase 1/2 Recruiting

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT06713369 2026-03-04

AZD5305

Phase 1 Recruiting

Neoplasm Metastasis, Neoplasms

NCT05938270 2026-02-24

ASCERTAIN

Phase 1 Recruiting

Prostatic Neoplasms

NCT04644068 2026-02-19

PETRA

Phase 1/2 Active not recruiting

BreastGastrointestinalGenitourinaryGynecologicThoracic

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT05573724 2024-06-18

Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid Malignancies

Phase 1 Completed

Neoplasms